亚洲社会药学
亚洲社会药学

快速检索 年期检索

›› 2014, Vol. 9 ›› Issue (3): 124-127.doi:

• Drug R&D • 上一篇    下一篇

Risk Aversion in New Drug Research and Development Market

ZHANG Xing, LIAN Gui-yu, CHEN Yu-wen   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2014-09-20 发布日期:2014-09-20

Risk Aversion in New Drug Research and Development Market

ZHANG Xing, LIAN Gui-yu, CHEN Yu-wen   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2014-09-20 Published:2014-09-20
  • Contact: LIAN Gui-yu

摘要： Objective To put forward the corresponding measures for risk aversion so as to improve the success ratio of new drug research
and development. Methods Literature review was conducted. Results and Conclusion Market risk of new drug research and
development mainly include the following aspects: product risk, demand risk, cost risk, competition risk and policy risk. Institutions
of new drug research and development need to evaluate the five risks and take measures to reduce market risk of new drug research
and development.

关键词: new drug research and development, market risk, risk aversion

Abstract: Objective To put forward the corresponding measures for risk aversion so as to improve the success ratio of new drug research
and development. Methods Literature review was conducted. Results and Conclusion Market risk of new drug research and
development mainly include the following aspects: product risk, demand risk, cost risk, competition risk and policy risk. Institutions
of new drug research and development need to evaluate the five risks and take measures to reduce market risk of new drug research
and development.

Key words: new drug research and development, market risk, risk aversion

版权所有 © 2019 《亚洲社会药学》

本系统由北京玛格泰克科技发展有限公司设计开发